0001225208-21-006981.txt : 20210423 0001225208-21-006981.hdr.sgml : 20210423 20210423212439 ACCESSION NUMBER: 0001225208-21-006981 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210423 FILED AS OF DATE: 20210423 DATE AS OF CHANGE: 20210423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STONE HEISZ LESLIE CENTRAL INDEX KEY: 0001235408 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 21851196 MAIL ADDRESS: STREET 1: C/O PUBLIC STORAGE STREET 2: 701 WESTERN AVENUE CITY: GLENDALE STATE: CA ZIP: 91201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 4 1 doc4.xml X0306 4 2021-04-23 0001099800 Edwards Lifesciences Corp EW 0001235408 STONE HEISZ LESLIE ONE EDWARDS WAY IRVINE CA 92614 1 Common Stock 2021-04-23 4 M 0 10000.0000 35.6767 A 29272.0000 D Common Stock 2021-04-23 4 S 0 6707.0000 97.5200 D 22565.0000 D Director Stock Option (Right to Acquire) 35.6767 2021-04-23 4 M 0 10000.0000 0.0000 D 2017-07-14 2023-07-13 Common Stock 10000.0000 9671.0000 D The Issuer requires that upon vesting or exercise of equity awarded after 2011, each director is required to hold the underlying common stock (net of any shares sold to cover the exercise price and applicable taxes) until the director's Board service ends. These shares underlying the options exercised were sold to cover the exercise price and applicable taxes. On May 29, 2020, the common stock of the Issuer split 3-for-1, resulting in the Reporting Person's ownership of additional shares of common stock and stock options. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Linda J. Park, Attorney-in-Fact 2021-04-23